test

Neb Obradovic

@Cormorant Asset Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.886BTotal holdings45
Assets growth rate8.94%Assets growth rate (2-Q avg)-7.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.886B in assets, with a quarterly growth rate of 8.94% and a 2-quarter average growth rate of -7.56%. The portfolio is managed by Neb Obradovic, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PCVXVaxcyte Inc
Recent Activity
Decreased -9.09%
6.06%
$114.27M
1M shares@ $114.27 avg price
ACLXArcellx Inc
Recent Activity
Decreased -18.03%
5.54%
$104.388M
1.25M shares@ $83.51 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Decreased -18.51%
2.99%
$56.21M
1.1M shares@ $51.1 avg price
MRUSMerus N V
Recent Activity
Decreased -11.9%
1.97%
$36.97M
740,000 shares@ $49.96 avg price
INSMInsmed Inc
Recent Activity
Decreased -25.92%
1.94%
$36.5M
500,000 shares@ $73.0 avg price
ALMSAlumis Inc
Recent Activity
Decreased 0%
1.22%
$22.934M
2.147M shares@ $10.68 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Decreased -7.92%
1.15%
$21.622M
2.325M shares@ $9.3 avg price
RYTMRhythm Pharmaceuticals Inc
Recent Activity
Decreased -15.78%
1.12%
$20.956M
400,000 shares@ $52.39 avg price
BHVNBiohaven Ltd
Recent Activity
Decreased -49.87%
1.07%
$20.086M
401,963 shares@ $49.97 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -6.06%
1.05%
$19.685M
1.55M shares@ $12.7 avg price